$ANVS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Annovis Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Annovis Bio, Inc.. Get notifications about new insider transactions in Annovis Bio, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2020 | ANVS | Annovis Bio, Inc. | Bruck Claudine | Director | Option Exercise | A | 4.39 | 20,000 | 87,800 | 20,000 | |
| Jul 06 2020 | ANVS | Annovis Bio, Inc. | White Mark K. | Director | Option Exercise | A | 4.39 | 20,000 | 87,800 | 20,000 | |
| Jul 06 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Option Exercise | A | 4.39 | 20,000 | 87,800 | 20,000 | |
| Apr 13 2020 | ANVS | Annovis Bio, Inc. | McGroarty Jeffrey Brian | Chief Financial Off ... | Option Exercise | A | 3.13 | 300,000 | 939,000 | 300,000 | |
| Apr 13 2020 | ANVS | Annovis Bio, Inc. | Maccecchini Maria-Luisa | President and CEO | Option Exercise | A | 3.13 | 300,000 | 939,000 | 300,000 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Option Exercise | C | 0.00 | 55,884 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Option Exercise | C | 0.00 | 1,593,118 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Option Exercise | C | 0.00 | 222,222 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Buy | C | 4.80 | 55,884 | 268,243 | 1,400,175 | 1.3 M to 1.4 M (+4.16 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Buy | C | 0.00 | 1,137,942 | 0 | 1,344,291 | 206.3 K to 1.3 M (+551.46 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Buy | C | 0.00 | 158,730 | 0 | 206,349 | 47.6 K to 206.3 K (+333.33 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Buy | P | 6.00 | 33,333 | 199,998 | 47,619 | 14.3 K to 47.6 K (+233.33 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Option Exercise | C | 0.00 | 11,176 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Option Exercise | C | 0.00 | 83,333 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Buy | C | 4.80 | 11,176 | 53,645 | 95,700 | 84.5 K to 95.7 K (+13.22 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Buy | C | 0.00 | 59,524 | 0 | 84,524 | 25 K to 84.5 K (+238.10 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Buy | P | 6.00 | 25,000 | 150,000 | 25,000 | 0 to 25 K |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Bruck Claudine | Director | Option Exercise | C | 0.00 | 1,117 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Bruck Claudine | Director | Option Exercise | C | 0.00 | 5,556 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Bruck Claudine | Director | Buy | C | 4.80 | 1,117 | 5,362 | 5,886 | 4.8 K to 5.9 K (+23.42 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Bruck Claudine | Director | Buy | C | 0.00 | 3,969 | 0 | 4,769 | 800 to 4.8 K (+496.13 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Bruck Claudine | Director | Buy | P | 6.00 | 800 | 4,800 | 800 | 0 to 800 |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | White Mark K. | Director | Option Exercise | C | 0.00 | 3,252 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | White Mark K. | Director | Option Exercise | C | 0.00 | 48,500 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | White Mark K. | Director | Option Exercise | C | 0.00 | 16,167 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | White Mark K. | Director | Buy | C | 4.80 | 3,252 | 15,610 | 51,177 | 47.9 K to 51.2 K (+6.79 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | White Mark K. | Director | Buy | C | 0.00 | 34,643 | 0 | 47,925 | 13.3 K to 47.9 K (+260.83 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | White Mark K. | Director | Buy | C | 0.00 | 11,548 | 0 | 13,282 | 1.7 K to 13.3 K (+665.97 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | White Mark K. | Director | Buy | P | 6.00 | 1,734 | 10,404 | 1,734 | 0 to 1.7 K |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Maccecchini Maria-Luisa | President and CEO | Option Exercise | C | 0.00 | 1,068,054 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Maccecchini Maria-Luisa | President and CEO | Option Exercise | C | 0.00 | 11,111 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Maccecchini Maria-Luisa | President and CEO | Buy | C | 0.00 | 762,896 | 0 | 978,775 | 215.9 K to 978.8 K (+353.39 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Maccecchini Maria-Luisa | President and CEO | Buy | C | 0.00 | 7,937 | 0 | 215,879 | 207.9 K to 215.9 K (+3.82 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Maccecchini Maria-Luisa | President and CEO | Buy | P | 6.00 | 1,600 | 9,600 | 207,942 | 206.3 K to 207.9 K (+0.78 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | McGroarty Jeffrey Brian | Chief Financial Off ... | Buy | P | 7.17 | 164 | 1,176 | 52,833 | 52.7 K to 52.8 K (+0.31 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | McGroarty Jeffrey Brian | Chief Financial Off ... | Buy | P | 7.15 | 19,336 | 138,252 | 52,669 | 33.3 K to 52.7 K (+58.01 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | McGroarty Jeffrey Brian | Chief Financial Off ... | Buy | P | 6.00 | 33,333 | 199,998 | 33,333 | 0 to 33.3 K |
Page: 1